# ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

> **NCT00290030** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 800 (actual)

## Conditions studied

- Prostatic Hyperplasia
- Acute Urinary Retention

## Interventions

- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00290030
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2009-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290030, "ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00290030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*